Member Info for Lazarus2

Thank you for sharing your knowledge with us oiks Funnyguy. You clearly have greater knowledge than most and I, for one, am grateful to you for dampening expectation and providing such insightful guidance - could you put some flesh on the bones of your comment and tell some of us here where we are going wrong in greater detail - thanks in advance.

If Sareum are holding out for a significant deal of some description, then you can expect any potential partner to want the i’s dotted and the t’s crossed. We must respect the fact that any future partner has to justify their actions to their own shareholders also.

Well said PCS.

@Damion - there is no suggestion that they will stick around long term and there is no "guarantee" of a return. The point is that these cheap shares at 20p will not hit the market in the way that Potnak is suggesting. When to dispose is entirely up to the investor(s). Don't overlook the warrants though. They wont convert the warrants until the sp is stable and at a premium to the 20p conversion price. Warrant conversion will act as a bit of a handbrake on the sp but not much of one given the numbers involved. Far more upside here than downside

Opened at 23.5p Surfie - the rest is smoke and mirrors from the spivs.

The subscription is a legally binding process and will be subject to confidentiality clauses. I am as sure as I can be that Sareum BoD will have handled questions with regards to the future pathway of Sareum (and not just 1801)and also, the unblinded data information just highlighted within the RNS. The shares issued will be in sticky hands as I have previously mentioned so the market will not be hampered by cheap shares.

I think the BoD have done very well and I am also confident that they would not break the rules just to snatch a quick win. All good and we should trust the process. My next point is that, as we have skipped Ph1b, haven't we saved time? I see no issue with dotting the i's and crossing the t's however long it takes.

Totally agree Bobbler. Nobody would stump up a significant sum of money on a gamble - there will have been due diligence required and I am sure that a presentation will have taken place. There is also a strong chance of further update by way of the forward looking statement.

I think that, in all of the reaction here, what is being missed is that the “dilution” Potnak is referring to is minimal and shares issued will be in sticky hands. Warrants won’t be exercised until there is decent profit. So must be anticipated.

The risk/reward ratio has strengthened significantly IMO due to the fact that for 11.8m shares we now have 1801 being advanced and a clear indication from Sareum that all is well. So the new value far outweighs the cost of getting there. Throw 737 potential into the mix by end December and 1802 to progress then this market cap is a snip. Don’t sweat the daily sp. I do not believe in pure market forces or mechanics. The sp is subject to Broker control, manipulation, suppression and naked shorting. Keep the market cap and the operational progress in sharp focus. All is good here….In fact, it just got better IMO. Oh! And Parker and the BoD have acted very astutely in the interest of shareholders and not themselves. Surely you can all see that!

Very good point Silver. Just typical of Government departments. Although some leapt on it to state there was a Sareum/compound problem. The BoD have weathered the storm very well and we are now well positioned to capitalise

Potnak - why is this bad news then? The news may not feed your confusing agenda but - as I see it - you will be topping up as per your previous posts. Have I got that wrong?

Nothing wrong here - we have a good compound and now we have cash for 11.8m shares. We are not going bust. This RNS allows the forward looking statement to be populated when results are released. It will be interesting to hear about the search for a new CEO. All good in my book and further development assured although more flesh on the bones need to be released going forwards

The spivs really don't want to increase the sp do they. No selling at all unless there is a large sell being worked. Can't see that though but you never know.

Potnak - I think the Notification RNS is a standard blurb as is the "About Sareum" section. Pretty standard stuff that all Companies use. I cannot see a standard wording RNS being interpreted as anything but. It will be interesting if Sareum do release results later than 15th but take your point about the word "expected" - we shall see.

Hi Enki - HBD posted a link on 03/10 at 1605hrs to the broker update and the £1.54 target price. You also responded then too. Have I missed something? I agree that no notification released by RNS yet.

Morning Funnyguy - I have changed the thread title in order to respond. Your post is not unreasonable but the questions you want answered have virtually all been discussed here and most agree we should have answers by/during December. The unblinded data etc: is imminent and I would expect Tuesdays results to provide a forward looking statement. If there is no deal then the only disappointment would be having to kick the can further down the road. I find that fully acceptable provided the data is good. Personally, I am hoping for unblinded data release this week ahead of results but who knows. We will definitely have more clarity after Tuesday

Yes - tough one to call correctly atm Potnak. As I posted earlier though, it is good to see that Sareum are not allowing anything to impeded progress and are looking for funding at Investeval which. I presume, means that Sareum are signalling that they are prepared to go it alone into Ph2a. In the event of no deal being negotiated then it is also a clue that funding news is to come further down the track. Interesting times.

I think that the attendance at Investeval next month is a belts and braces move and very positive. If we are in negotiations then we are sending a message that we are not going to cave in due to lack of funding. Should talks fail Sareum may well attract funding at Investeval in order to be able to go it alone if needs be. Eminently sensible in my view and should provide a sound alternative to a license deal should we require one. Very sound management in my view with progress clearly not being allowed to stall

And a plague of locusts was visited upon the houses of Surfie and PH and all other naysayers and condemners

And The Lord sayeth " And a RNS shall appear, not just one but a few. These will deliver light out of darkness and ye shall all reap what ye have sown" (Other Religions are also available)

Something along those lines anyway! Not long and plenty to come throughout the current Quarter.

Good while it lasted but the BIO conference in Stockholm is back up on the events page as is a new event which is the LSX Investival in London 18th Novemebr - an event for connecting Life Science and Healthcare Execs: with Capital and Partners.

Aber - really!! We have discussed this to death and there is a strict process to follow - no one man is autonomous within the BoD and any decisions are collective. To think this individual could have autonomy over the other parties requirements, offer and outcome is just La-La land thinking I’m afraid. Play the ball and not the man.